Quarterly Result5 Nov 2026, 07:23 pm
Fredun Pharma Declares Un-Audited Q2 FY27 Results
AI Summary
Fredun Pharmaceuticals Ltd announced its un-audited financial results for the Quarter and Half-Year Ended September 30, 2026. The Board of Directors also approved an application to list the company's equity shares on the National Stock Exchange (NSE). The trading window for company insiders closed on October 1, 2026, and will reopen 48 hours after the declaration of the board meeting outcome. The company also reported on share capital changes due to bonus share allotment and warrant conversion.
Key Highlights
- Company declared un-audited financial results for Q2 FY27.
- Board approved application for NSE listing.
- Trading window for insiders was closed.
- Bonus shares and warrant conversions impacted share capital.
- Statutory auditors issued an unmodified limited review report.
Price Impact
More from FREDUN